130 related articles for article (PubMed ID: 15378094)
1. Fatigue and depression in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation.
El-Banna MM; Berger AM; Farr L; Foxall MJ; Friesth B; Schreiner E
Oncol Nurs Forum; 2004 Sep; 31(5):937-44. PubMed ID: 15378094
[TBL] [Abstract][Full Text] [Related]
2. Symptom burden in patients undergoing autologous stem-cell transplantation.
Anderson KO; Giralt SA; Mendoza TR; Brown JO; Neumann JL; Mobley GM; Wang XS; Cleeland CS
Bone Marrow Transplant; 2007 Jun; 39(12):759-66. PubMed ID: 17438588
[TBL] [Abstract][Full Text] [Related]
3. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.
Danaher EH; Ferrans C; Verlen E; Ravandi F; van Besien K; Gelms J; Dieterle N
Oncol Nurs Forum; 2006 May; 33(3):614-24. PubMed ID: 16676017
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of massage therapy and handling touch on caregivers of patients undergoing autologous hematopoietic stem cell transplant.
Rexilius SJ; Mundt C; Erickson Megel M; Agrawal S
Oncol Nurs Forum; 2002 Apr; 29(3):E35-44. PubMed ID: 11979292
[TBL] [Abstract][Full Text] [Related]
5. Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation.
Frick E; Borasio GD; Zehentner H; Fischer N; Bumeder I
Psychooncology; 2004 Feb; 13(2):116-24. PubMed ID: 14872530
[TBL] [Abstract][Full Text] [Related]
6. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation.
Hjermstad MJ; Loge JH; Evensen SA; Kvaløy SO; Fayers PM; Kaasa S
Bone Marrow Transplant; 1999 Dec; 24(11):1219-28. PubMed ID: 10642812
[TBL] [Abstract][Full Text] [Related]
7. Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation?
Frick E; Motzke C; Fischer N; Busch R; Bumeder I
Psychooncology; 2005 Sep; 14(9):759-70. PubMed ID: 15744779
[TBL] [Abstract][Full Text] [Related]
8. Differences in fatigue by treatment methods in women with breast cancer.
Woo B; Dibble SL; Piper BF; Keating SB; Weiss MC
Oncol Nurs Forum; 1998 Jun; 25(5):915-20. PubMed ID: 9644708
[TBL] [Abstract][Full Text] [Related]
9. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy.
Payne JK; Held J; Thorpe J; Shaw H
Oncol Nurs Forum; 2008 Jul; 35(4):635-42. PubMed ID: 18591167
[TBL] [Abstract][Full Text] [Related]
10. Feasibilty of a sleep intervention during adjuvant breast cancer chemotherapy.
Berger AM; VonEssen S; Khun BR; Piper BF; Farr L; Agrawal S; Lynch JC; Higginbotham P
Oncol Nurs Forum; 2002; 29(10):1431-41. PubMed ID: 12432414
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study.
Payne J; Piper B; Rabinowitz I; Zimmerman B
Oncol Nurs Forum; 2006 Jul; 33(4):775-83. PubMed ID: 16858459
[TBL] [Abstract][Full Text] [Related]
12. The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy.
Payne JK
Oncol Nurs Forum; 2002 Oct; 29(9):1334-40. PubMed ID: 12370703
[TBL] [Abstract][Full Text] [Related]
13. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life.
Byar KL; Berger AM; Bakken SL; Cetak MA
Oncol Nurs Forum; 2006 Jan; 33(1):E18-26. PubMed ID: 16470230
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of nursing education as an intervention to decrease fatigue in Turkish patients receiving chemotherapy.
Yesilbalkan OU; Karadakovan A; Göker E
Oncol Nurs Forum; 2009 Jul; 36(4):E215-22. PubMed ID: 19581225
[TBL] [Abstract][Full Text] [Related]
15. Patients' perceptions of fatigue in response to biochemotherapy for metastatic melanoma: a preliminary study.
Fu MR; Anderson CM; McDaniel R; Armer J
Oncol Nurs Forum; 2002 Jul; 29(6):961-6. PubMed ID: 12096293
[TBL] [Abstract][Full Text] [Related]
16. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy.
Berger AM
Oncol Nurs Forum; 1998; 25(1):51-62. PubMed ID: 9460773
[TBL] [Abstract][Full Text] [Related]
17. High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.
Wadhwa PD; Fu P; Koc ON; Cooper BW; Fox RM; Creger RJ; Bajor DL; Bedi T; Laughlin MJ; Payne J; Gerson SL; Lazarus HM
Biol Blood Marrow Transplant; 2005 Jan; 11(1):13-22. PubMed ID: 15625540
[TBL] [Abstract][Full Text] [Related]
18. The relationship between learned resourcefulness and cancer-related fatigue in patients with non-Hodgkin lymphoma.
Menshadi N; Bar-Tal Y; Barnoy S
Oncol Nurs Forum; 2013 Mar; 40(2):133-8. PubMed ID: 23448738
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
20. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study.
So WK; Marsh G; Ling WM; Leung FY; Lo JC; Yeung M; Li GK
Oncol Nurs Forum; 2009 Jul; 36(4):E205-14. PubMed ID: 19581224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
